ARID1A serves as a receivable biomarker for the resistance to EGFR-TKIs in non-small cell lung cancer

Overview of attention for article published in Molecular Medicine, October 2021

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (54th percentile)
Good Attention Score compared to outputs of the same age and source (65th percentile)

Mentioned by

twitter: 4 X users

reddit: 1 Redditor

Readers on

mendeley: 13 Mendeley

Summary X Reddit

So far, Altmetric has seen 1 Reddit thread.

ARID1A serves as a receivable biomarker for the resistance to EGFR-TKIs in non-small cell lung cancer

User montaukwhaler, in the non small cell lung cancer subreddit, 02 Nov 2021

This page shows the most recent Reddit threads that mention this research output.

Click here to find out how to access more activity.